The global plant-derived proteins market is on track to achieve a valuation of USD 105 million by the end of 2022. This growth is fueled by increasing research and development activities aimed at developing more effective drugs and biologics, particularly in key markets such as India, China, the USA, and the UK.
Plant-derived proteins have emerged as critical components in the pharmaceutical and biotechnology sectors, owing to their biocompatibility, sustainability, and potential to replace animal-based proteins in drug formulations. These proteins are being increasingly utilized in therapeutic applications, vaccines, and nutraceuticals, addressing the growing demand for eco-friendly and efficient biologics.
The market is benefiting from heightened investments in biopharmaceutical R&D and supportive government policies promoting plant-based innovations. Additionally, advancements in extraction and purification technologies are enabling the production of high-quality plant-derived proteins, further bolstering market growth.
As the sector evolves, leading companies are focusing on expanding their product pipelines and strengthening collaborations with research institutions. With its transformative potential in drug development and healthcare, the plant-derived proteins market is set to play a pivotal role in shaping the future of sustainable pharmaceutical innovations.
Key Growth Drivers
- Research and Development: Enhanced R&D efforts are focused on developing plant-derived proteins for pharmaceutical applications, which is expected to bolster market growth.
- Health Trends: Growing awareness of health benefits associated with plant-based proteins is influencing consumer preferences towards these products.
- Regulatory Support: Favorable regulations surrounding the use of plant-derived ingredients in food and pharmaceuticals are facilitating market expansion.
Competitive Landscape
Key players in the plant derived proteins market are focusing in adoption expansion strategies such as new product launch and product approval to gain competitive edge. Some of the other companies are aiming at collaboration, merger, and acquisition with other players to expand their market share. For instance,
- In April 2021, Protalix BioTherapeutics, Inc., an Israeli-based plant-based enzyme manufacturing company, announced receiving Complete Response Letter (CRL) from the USA Food and Drug Administration (FDA) for its new product pegunigalsidase alfa (PRX–102), a recombinant alpha-Galactosidase-A protein.
Key Companies Profiled
Amgen Inc; Abbott Laboratories; AstraZeneca; Merck KGaA; Baxter International; Boehringer Ingelheim; Chugai Pharmaceutical; Diasome Pharmaceuticals; Eli Lilly & Company; Protalix Biotherapeutic; F. Hoffmann-La Roche; Generex Biotechnology; GeneScience Pharmaceuticals; Group Biogen Idec Inc; Hualan Biological Engineering; Johnson & Johnson; Kyowa Hakko Kirin; Novo Nordisk
A Full Report Overview
Plant Derived Proteins Market by Category
By Plant:
- Tobacco
- Rice
- Carrot
- Barley
- Others
By Protein:
- Industrial Proteins& Enzymes
- Therapeutic Proteins
- Blood Proteins
- Cell Culture Functional Proteins
- Others
By Platform:
- In-vitro Cell Culture Systems
- Whole Plants
- Others
By Application:
- Regenerative Medicine-Therapeutic Agents
- Regenerative Medicine-Functional Material
- Cell Culture Application
- Others
By End User:
- Biopharmaceutical Companies
- Academic & Research Institutes
- Contract Research Organization (CROs)
- Contract Manufacturing Organization (CMOs)
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube